Suppr超能文献

心脏移植术后巨细胞病毒性肺炎

Cytomegalovirus pneumonitis after cardiac transplantation.

作者信息

Schulman L L, Reison D S, Austin J H, Rose E A

机构信息

Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10032.

出版信息

Arch Intern Med. 1991 Jun;151(6):1118-24.

PMID:1645949
Abstract

To evaluate the incidence and clinical features of cytomegalovirus (CMV) pneumonitis after cardiac transplantation, we identified 27 (16%) of 171 consecutive recipients in whom CMV pneumonitis was confirmed by strict diagnostic criteria. Cytomegalovirus pneumonitis occurred in 6 (30%) of 20 patients treated with azathioprine and prednisone, and 8 (25%) of 32 patients treated with azathioprine, cyclosporine, and prednisone, but only 13 (11%) of 119 patients treated with cyclosporine and prednisone. The incidence of CMV pneumonitis was not related to recipient preoperative CMV titers or to postoperative cardiac rejection, but there was a trend toward increased CMV pneumonitis in patients who received organs from CMV-positive donors. Mean onset of CMV pneumonitis was 2.9 +/- 1.6 (SD) months after transplantation. In the azathioprine-prednisone group, CMV was always associated with at least one other respiratory pathogen (Aspergillus, n = 5; Pneumocystis carinii, n = 2). In the two cyclosporine groups, CMV was either the sole respiratory pathogen (n = 9), or associated with P carinii (n = 11). Roentgenographically, diffuse bilateral hazy pulmonary opacities were present in 19 (70%) of 27 patients, but focal subsegmental opacity (26%), small pleural effusion (26%), and lobar consolidation (7%) were also observed. When bronchoscopy was performed, bronchoalveolar lavage was the most sensitive technique for detecting CMV (72%), whereas transbronchial biopsy (39%) and combined washings and brushings (33%) were relatively insensitive techniques. Respiratory failure and death occurred in 52% and 44%, respectively, of patients with CMV pneumonitis. In this population of immunocompromised hosts: (1) CMV pneumonitis, alone or with other respiratory pathogens, was a major cause of morbidity and mortality; (2) localized roentgenographic opacity did not exclude CMV pneumonitis; (3) bronchoalveolar lavage was the most sensitive bronchoscopic technique for detecting CMV pneumonitis.

摘要

为评估心脏移植术后巨细胞病毒(CMV)肺炎的发病率及临床特征,我们在171例连续接受心脏移植的患者中,依据严格诊断标准确诊了27例(16%)CMV肺炎患者。在接受硫唑嘌呤和泼尼松治疗的20例患者中,有6例(30%)发生CMV肺炎;在接受硫唑嘌呤、环孢素和泼尼松治疗的32例患者中,有8例(25%)发生CMV肺炎;而在接受环孢素和泼尼松治疗的119例患者中,仅有13例(11%)发生CMV肺炎。CMV肺炎的发病率与受体术前CMV滴度或术后心脏排斥反应无关,但接受来自CMV阳性供体器官的患者中,CMV肺炎有增加趋势。CMV肺炎的平均发病时间为移植后2.9±1.6(标准差)个月。在硫唑嘌呤-泼尼松组,CMV感染总是与至少一种其他呼吸道病原体相关(曲霉菌,5例;卡氏肺孢子虫,2例)。在两个环孢素组中,CMV要么是唯一的呼吸道病原体(9例),要么与卡氏肺孢子虫相关(11例)。X线表现上,27例患者中有19例(70%)出现双侧弥漫性模糊肺浸润影,但也观察到局灶性亚段性浸润影(26%)、少量胸腔积液(26%)和肺叶实变(7%)。进行支气管镜检查时,支气管肺泡灌洗是检测CMV最敏感的技术(72%),而经支气管活检(39%)和联合冲洗及刷检(33%)相对不敏感。CMV肺炎患者分别有52%和44%发生呼吸衰竭和死亡。在这群免疫功能低下的宿主中:(1)CMV肺炎单独或与其他呼吸道病原体共同感染,是发病和死亡的主要原因;(2)X线局限性浸润影不能排除CMV肺炎;(3)支气管肺泡灌洗是检测CMV肺炎最敏感的支气管镜技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验